Market Cap 3.55B
Revenue (ttm) 10.90M
Net Income (ttm) -322.30M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -2,956.88%
Debt to Equity Ratio 0.00
Volume 3,150,800
Avg Vol 1,401,454
Day's Range N/A - N/A
Shares Out 120.21M
Stochastic %K 3%
Beta 1.02
Analysts Strong Sell
Price Target $67.07

Latest News on RNA

Avidity Biosciences Honors Rare Disease Day®

Feb 29, 2024, 12:00 PM EST - 1 year ago

Avidity Biosciences Honors Rare Disease Day®


Avidity Stock Soars on Collaboration Deal With Bristol Myers

Nov 28, 2023, 7:43 AM EST - 1 year ago

Avidity Stock Soars on Collaboration Deal With Bristol Myers

BMY


Avidity Biosciences: An Interesting Diversification

Apr 25, 2023, 5:41 AM EDT - 2 years ago

Avidity Biosciences: An Interesting Diversification